Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Next Generation Sequencing of GATC Biotech AG Accredited by German DAkkS

Published: Monday, December 03, 2012
Last Updated: Monday, December 03, 2012
Bookmark and Share
GATC Biotech customers can expect highest quality standards for Next Generation Sequencing projects from official accreditation.

Being the first in Europe, the Next Generation Sequencing Laboratories of the Constance Genome and Diagnostics Centre has been accredited according to ISO 17025 from the national accreditation body for the Federal Republic of Germany (DAkks). The independent governmental institution has acknowledged the high quality standard of the sequencing service on technology platforms Illumina HiSeq and Roche GSFLX sequencing.

“As an accredited service provider we assure our customers the latest state-of-the-art standards in our methods, technologies and data quality at all times. This is especially important to our customers from the industry or diagnostics. A reliable and continuously high quality of the analysis service is of great importance to them. The accreditation allows all customers to compare the quality of service providers on the international sequencing market”, explains Dr. Marcus Benz, COO of GATC Biotech AG.

“While inspecting the laboratories, we met a very qualified and motivated team that has developed a high competency for the complex analysis. Apart from the staff and the excellent equipment, the LIMS system has to be highlighted. This in-house developed software system allows a wide monitoring of the processes and contributes especially to internal quality management”, says the DAkkS expert.

Since June 2012, the accreditation according to ISO 17025 has been official and has been confirmed by extensive audits. The Genome and Diagnostics Centre of GATC Biotech in Constance meets essential requirements for the competence of analysis and calibration laboratories such as DIN EN ISO/IEC 17025, DIN EN ISO 9001 and all further conditions. The compliance of standards is monitored by the DAkkS regularly.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GATC Biotech Present Three Accredited NGS Platforms Under One Roof
With official accreditation of another sequencing platform, GATC Biotech presents the worldwide first trio of accredited NGS platforms under one roof.
Tuesday, April 23, 2013
GATC Biotech and LifeCodexx Complete Recruitment of Blood Samples for Clinical Study
The partners successfully completed the recruitment of over 500 blood samples required for the clinical study of the non-invasive prenatal diagnostic test for the determination of trisomy 21.
Tuesday, January 10, 2012
GATC Biotech and ETH Zurich to Establish Method for Food Quality Assurance
New methods will provide valuable information concerning food safety quality control, optimization of production yields as well as food production processes.
Friday, July 22, 2011
GATC Biotech Opens Third Sequencing Laboratory in Europe
Facilities will be situated in Düsseldorf, Germany.
Wednesday, November 17, 2010
GATC Biotech to Sequence 100,000 Human Genomes by 2014
PacBio RS to support studies on rare variant, and structural variations and methylation patterns.
Wednesday, September 29, 2010
GATC Biotech Sequences Pediatric Brain Tumors for the International Cancer Genome Consortium
GATC Biotech to sequence samples from brain tumors in children for the world’s largest cancer research project.
Tuesday, May 18, 2010
GATC Biotech Orders Europe’s First HiSeq 2000 for Commercial Use
Illumina’s latest sequencing system to be installed in the Constance laboratories.
Friday, January 22, 2010
GATC Biotech Launches Human Genome Sequencing Service at BioEurope
GATC hopes to boost the move towards personalized medicine by sequencing up to 100 genomes by the end of 2010.
Friday, November 16, 2007
GATC Biotech will use Genome Sequencer Technology from Roche
GATC plans to use the Genome Sequencer to offer its customers all the applications within this technology, with a special focus on in-depth analysis of whole transcriptomes.
Wednesday, March 07, 2007
Scientific News
Researchers Develop Classification Model for Cancers Caused by KRAS
Most frequently mutated cancer gene help oncologists choose more effective cancer therapies.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Key to Natural Detoxifier’s Reactivity Discovered
Results have implications for health, drug design and chemical synthesis.
New Treatment for Obesity Developed
Researchers at the University of Liverpool, working with a global healthcare company, have helped develop a new treatment for obesity.
New Protein Found in Immune Cells
Immunobiologists from the University of Freiburg discover Kidins220/ARMS in B cells and demonstrate its functions.
Will Brain Palpation Soon Be Possible?
Researchers have developed non-invasive brain imaging technique which provides the same information as physical palpation.
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Groundbreaking Computer Program Diagnoses Cancer in Two Days
Researchers have combined genetics with computer science and created a new diagnostic technology can with 85 per cent certainty identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos